CisplatinAntineoplastic AgentsPlatinumAntineoplastic Combined Chemotherapy ProtocolsDrug Resistance, NeoplasmDNA AdductsChemotherapy, AdjuvantCell Line, TumorDoxorubicinEmployer Health CostsEtoposideApoptosisCombined Modality TherapyNeoplasmsPaclitaxelTreatment OutcomeAntineoplastic Agents, PhytogenicPrescription FeesCyclophosphamideBreast NeoplasmsDNA DamageDrug Screening Assays, AntitumorOvarian NeoplasmsDisease-Free SurvivalNeoadjuvant TherapyCell SurvivalDrug Administration ScheduleLung NeoplasmsSurvival AnalysisDrug Delivery SystemsNeoplasm StagingFluorouracilSurvival RateVinblastineCarboplatinDose-Response Relationship, DrugPrognosisDeoxycytidineMethotrexateTaxoidsIfosfamideTumor Cells, CulturedInduction ChemotherapyNeoplasm Recurrence, LocalBleomycinCarcinoma, Non-Small-Cell LungVomitingAntimetabolites, AntineoplasticGene Expression Regulation, NeoplasticTesticular NeoplasmsCell ProliferationNauseaAdenocarcinomaNeutropeniaAntineoplastic Agents, AlkylatingFollow-Up StudiesSalvage TherapyOrganoplatinum CompoundsTime FactorsNeoplasm MetastasisAnthracyclinesCytarabineChemotherapy, Cancer, Regional PerfusionInfusions, IntravenousLeukopeniaCamptothecinCarcinoma, Squamous CellNeoplasms, Germ Cell and EmbryonalMitomycinRadiotherapy, AdjuvantHead and Neck NeoplasmsRadiotherapyTransplantation, AutologousCarmustinePlatinum CompoundsProspective StudiesAntiemeticsStomach NeoplasmsTegafurLymphoma, Non-HodgkinAntibiotics, AntineoplasticDacarbazineOsteosarcomaGerminomaInfusions, Intra-ArterialHodgkin DiseaseClinical Trials as TopicGranulocyte Colony-Stimulating FactorKaplan-Meier EstimateVindesineColorectal NeoplasmsBone NeoplasmsPeritoneal NeoplasmsBrain NeoplasmsLomustineLiver NeoplasmsRadiotherapy DosageCarcinomaOxonic AcidMelphalan